Global Vascular Closure Devices (VCD) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

In this report, the Vascular Closure Devices (VCD) Market has been segmented by Product, Access Site, End Use and Geography.

Vascular Closure Devices (VCD) Market, Segmentation by Product

The Vascular Closure Devices (VCD) Market has been segmented by Product into Active Approximators, Passive Approximators and External hemostatic devices.

Active Approximators

Active approximators are suture-based or clip-based devices designed to mechanically close vascular access sites post-procedure. In 2024, this segment accounted for approximately 65.7% of the total revenue in the global vascular closure device market. Their ability to provide immediate hemostasis and reduce time to ambulation makes them a preferred choice in interventional cardiology and radiology procedures.

Passive Approximators

Passive approximators, including collagen plugs and sealant or gel-based devices, facilitate vascular closure by promoting natural clot formation. They are favored for their ease of use and reduced complication rates. In 2020, passive approximators held the largest share of the vascular closure devices market, attributed to the increasing number of approvals and their suitability for a wide range of patients.

External Hemostatic Devices

External hemostatic devices, such as compression pads and hemostatic patches, are applied externally to achieve hemostasis at the vascular access site. While they offer a non-invasive approach, their market share is comparatively smaller. However, they are gaining traction in scenarios where minimally invasive techniques are preferred, and in patients with contraindications to internal devices.

Vascular Closure Devices (VCD) Market, Segmentation by Access Site

The Vascular Closure Devices (VCD) Market has been segmented by Access Site into Femoral, Radial and Others.

Femoral

The femoral artery remains the most commonly used access site for vascular interventions, accounting for nearly 80% of all procedures in 2024. This dominance is due to the artery's large diameter and ease of access, which support complex interventions such as angioplasty and stent placement. The high usage rate of femoral access drives substantial demand for vascular closure devices to ensure effective post-procedure hemostasis.

Radial

Radial access is gaining widespread adoption due to its lower complication rates and enhanced patient comfort. Though it currently represents a smaller portion of procedures compared to femoral access, its popularity is rapidly growing in cardiovascular catheterization. The rise of transradial interventions is accelerating the need for specialized closure devices tailored for the radial artery.

Others

This category includes alternative access points such as the brachial artery or pedal arteries, typically used when femoral or radial access is unsuitable. These sites are crucial in complex or high-risk patients and require customized closure solutions. Although representing a smaller market share, the demand for safety and efficiency in these procedures is contributing to gradual growth in this segment.

Vascular Closure Devices (VCD) Market, Segmentation by End Use

The Vascular Closure Devices (VCD) Market has been segmented by End Use into Acute Care Facilities, Hospitals and Clinics.

Acute Care Facilities

Acute care facilities are the primary end-users of vascular closure devices, accounting for approximately 61% of the market share in 2024. The high demand in this segment is driven by the need for immediate hemostasis in emergency situations, such as trauma cases and urgent cardiovascular interventions. The utilization of advanced imaging technologies and the emphasis on rapid patient stabilization further propel the adoption of vascular closure devices in these settings

Hospitals

Hospitals represent a significant segment in the vascular closure devices market, owing to the increasing number of interventional procedures performed in these settings. The availability of skilled healthcare professionals and comprehensive medical infrastructure facilitates the effective use of these devices. Additionally, the rising prevalence of chronic diseases necessitating catheterization procedures contributes to the steady demand for vascular closure devices in hospitals

Clinics

Clinics are emerging as important end-users in the vascular closure devices market, particularly with the growing trend of outpatient procedures. The preference for minimally invasive techniques and the need for efficient patient turnover drive the adoption of vascular closure devices in these settings. Clinics benefit from the reduced recovery times and enhanced patient comfort associated with the use of these devices

Vascular Closure Devices (VCD) Market, Segmentation by Geography

In this report, the Vascular Closure Devices (VCD) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Vascular Closure Devices (VCD) Market Share (%), by Geographical Region

North America

North America dominated the global vascular closure devices market in 2024, accounting for approximately 44.4% of the total market share. This dominance is attributed to the high prevalence of cardiovascular diseases, a well-established healthcare infrastructure, and the presence of leading medical device manufacturers. The region's advanced medical facilities and the high adoption rate of innovative medical technologies have significantly contributed to the market's growth

Europe

Europe holds a significant share in the vascular closure devices market, driven by a growing aging population and a high incidence of chronic illnesses requiring long-term treatments. Countries like Germany, the UK, and France are leading contributors, owing to their robust healthcare systems and increased healthcare expenditure. The demand for minimally invasive procedures and advanced medical technologies further supports market expansion in this region

Asia Pacific

The Asia Pacific region is anticipated to witness the fastest growth in the vascular closure devices market during the forecast period. Factors such as a rising geriatric population, increasing prevalence of cardiovascular diseases, and improving healthcare infrastructure in countries like China, India, and Japan contribute to this growth. Moreover, government initiatives aimed at enhancing healthcare accessibility and affordability are expected to boost the adoption of vascular closure devices in this region

Middle East and Africa

The Middle East and Africa region is experiencing steady growth in the vascular closure devices market, driven by the increasing prevalence of cardiovascular diseases and the expansion of healthcare infrastructure. Countries like South Africa, Saudi Arabia, and the UAE are investing in advanced medical technologies and minimally invasive procedures, which is expected to propel market growth in this region

Latin America

Latin America is emerging as a potential market for vascular closure devices, with countries like Brazil and Mexico leading the way. The region's growth is supported by the increasing prevalence of cardiovascular diseases, rising healthcare expenditure, and the adoption of minimally invasive procedures. Efforts to improve healthcare infrastructure and access to advanced medical technologies are expected to further drive market growth in Latin America

This report provides an in depth analysis of various factors that impact the dynamics of Global Vascular Closure Devices (VCD) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Increasing cardiovascular disease prevalence
• Technological advancements in VCDs
• Rising geriatric population globally

• Growing minimally invasive procedures: The global vascular closure devices (VCD) market is experiencing robust growth, largely fueled by the increasing adoption of minimally invasive procedures. As medical technology advances, there's a growing preference for minimally invasive techniques among both patients and healthcare providers due to their numerous benefits, including reduced recovery times, shorter hospital stays, and lower risk of complications. Vascular closure devices play a crucial role in these procedures by facilitating efficient and safe closure of puncture sites in blood vessels, thus minimizing the risk of bleeding and other post-procedural complications.

  One of the key factors driving the growth of the VCD market is the rising prevalence of cardiovascular diseases worldwide. Conditions such as coronary artery disease, peripheral artery disease, and structural heart defects require various interventional procedures, such as angioplasty, stenting, and transcatheter aortic valve replacement (TAVR). With an aging population and changing lifestyles contributing to the increasing incidence of these conditions, there's a growing demand for minimally invasive treatments, driving the adoption of vascular closure devices.

  Technological advancements in vascular closure devices are also contributing to market growth. Manufacturers are continuously innovating to develop devices that offer improved efficacy, safety, and ease of use. For instance, newer generations of VCDs feature enhanced sealing mechanisms, reduced deployment times, and compatibility with a wide range of catheter sizes, making them suitable for various anatomical considerations and procedural requirements. These innovations not only enhance patient outcomes but also streamline procedural workflows for healthcare providers, further driving the adoption of VCDs in minimally invasive interventions.

Restraints

• High costs of devices
• Risk of complications
• Stringent regulatory approvals

• Limited reimbursement policies: The global vascular closure devices (VCD) market has witnessed significant growth in recent years, driven by an increasing prevalence of cardiovascular diseases and a growing preference for minimally invasive procedures. However, one of the major challenges faced by the market is limited reimbursement policies. Reimbursement policies play a crucial role in determining the adoption rate of VCDs, as they directly impact the affordability of these devices for patients. In many regions, reimbursement policies for VCDs may be limited or inconsistent, leading to financial constraints for both patients and healthcare providers.

  Limited reimbursement policies can pose a barrier to the widespread adoption of VCDs, particularly in emerging economies where healthcare infrastructure and insurance coverage may be less developed. Patients may face difficulties in accessing these devices due to out-of-pocket expenses, while healthcare providers may hesitate to offer VCD procedures if reimbursement rates are inadequate. Moreover, the lack of uniform reimbursement policies across different regions can create challenges for manufacturers seeking to penetrate new markets and expand their customer base.

  To address the issue of limited reimbursement policies, stakeholders in the VCD market, including manufacturers, healthcare providers, and policymakers, need to collaborate to advocate for improved reimbursement frameworks. This may involve engaging with insurance companies and government agencies to demonstrate the clinical and economic benefits of VCDs compared to traditional vascular closure methods. Additionally, investments in health infrastructure and regulatory reforms may be necessary to create a more conducive environment for the adoption of VCDs, ensuring that patients have equitable access to these life-saving technologies.

Opportunities

• Emerging markets expansion
• Development of new products
• Increasing healthcare expenditure

• Collaborations and partnerships: The global vascular closure devices (VCD) market has witnessed significant growth in recent years, primarily driven by the rising prevalence of cardiovascular diseases and the increasing demand for minimally invasive procedures. Collaborations and partnerships have played a crucial role in shaping the competitive landscape of this market. Companies are leveraging partnerships to enhance their product offerings, expand their market reach, and accelerate innovation. For instance, major players in the VCD market often collaborate with healthcare providers and research institutions to conduct clinical trials and gather real-world evidence to validate the safety and efficacy of their devices. These collaborations not only facilitate the development of advanced VCDs but also contribute to improving patient outcomes by ensuring the adoption of best practices.

  Collaborations between VCD manufacturers and healthcare organizations enable the customization of closure solutions to meet the specific needs of different patient populations. By collaborating with healthcare providers, companies gain valuable insights into clinical workflows and patient preferences, which helps in the design and development of VCDs that offer superior performance and patient comfort. Additionally, partnerships with distribution networks and regulatory agencies enable VCD manufacturers to navigate complex market dynamics and ensure compliance with regulatory requirements across different geographies. Through strategic collaborations, companies can establish a strong presence in key markets and effectively address the evolving needs of healthcare providers and patients.

  Collaborations and partnerships play a pivotal role in fostering innovation in the VCD market. By pooling together resources and expertise, companies can accelerate the development of next-generation VCDs that incorporate advanced technologies such as robotics, artificial intelligence, and biocompatible materials. Collaborations between VCD manufacturers and technology companies enable the integration of digital health solutions, such as remote monitoring and data analytics, to optimize procedural outcomes and post-operative care. Additionally, partnerships with academic institutions and research organizations facilitate knowledge exchange and promote the translation of scientific discoveries into clinically relevant solutions. Overall, collaborations and partnerships are essential drivers of growth and innovation in the global vascular closure devices market, enabling companies to address unmet medical needs and improve patient care.

Key players in Global Vascular Closure Devices (VCD) Market include:

• Abbott Laboratories
• Cardinal Health Inc
• Terumo Corporation
• Merit Medical Systems Inc
• Medtronic plc
• Teleflex Incorporated
• B. Braun Melsungen AG
• Vasorum Ltd
• Essential Medical Inc
• Morris Innovative Inc

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis